Compare Bank China Construction Bank Indonesia Tbk. (MCOR) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank China Construction Bank Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Bank China Construction Bank Indonesia Tbk. trades at Rp69 (market cap 2.59T, 1.91M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Bank China Construction Bank Indonesia Tbk. is far larger — about 24.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MCOR | SCPI | |
|---|---|---|
Market Cap | 2.59T | 104.4B |
Volume | 1.91M | — |
Lot | 19.07K | — |
Turnover | 132.14M | — |
Average Price | 69.29 | — |
Value | 132.14M | — |
Indicative Equilibrium Price | 69 | — |
Indicative Equilibrium Volume | 113 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank China Construction Bank Indonesia Tbk.
PT Bank Multicor (Bank) was established under its original name of PT Multinational Finance Corporation base on notarial deed No.4 of Mr Bagijo, S.H, dated on Apr 2, 1974. The Company’s articles of association has been amended several times, most recently by notarial deed No. 143 of Eliwati Tjitra, S.H., dated Mar 21, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering. The Bank's name was changed to PT Bank Windu Kentjana International Tbk.
Read more on MCOR →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
